Wilms tumors: How genes and imprinting pave the way for cancer

A research team at the Biocenter of Julius-Maximilians-Universität Würzburg (JMU), together with cooperation partners at the Wellcome Sanger Institute in Cambridge (UK), has taken a significant step towards understanding Wilms’ tumors, malignant kidney tumors in young children. Using samples from the Wilms tumor biobank, the team was able to systematically decipher the hereditary predisposition for Wilms tumors in a large cohort. The results have now been published in the journal Genome…

Continue Reading


News Source: www.sciencedaily.com

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *